Is IBLHL a Buy? IBLHL Smart-Money Analysis, Fair Value & Signal

ZEME verdict — Early Load phase

Constructive — ZEME sees smart-money accumulation; check the entry vs the load zone.

What ZEME decides about IBLHL, and why

ILLIQUID — earned weight 0 of 1.00, the summed measured record of the backing engines.

Because. Rs2.0mn/day — too thin to exit a 5-10 lac ticket

Risk. stop 38.85 (6.3% below close) — exit there

The case against. against: phase EARLY LOAD (median -0.58% over 595 completed runs, 39.8% win) — the median run in this phase LOSES; 28% above fair value

What happens next after the Early Load phase

Measured from 612 completed Early Load runs in ZEME's recorded phase history — these are frequencies of what actually happened next, not forecasts:

WATCHING — 64.7% of the time (n=396)
LOADING — 20.3% of the time (n=124)
LAUNCHING — 7.4% of the time (n=45)
FULLY LOADED — 3.8% of the time (n=23)
RUNNING — 2.1% of the time (n=13)
EXITED — 1.5% of the time (n=9)

Typical stay in this phase: 3 sessions (median). measured from 2026-07-16

ZEME publishes the case against its own signals, and the base rate any share has to beat. Educational analysis, not investment advice.

Price	Rs 41.37
ZEME fair value	Rs 29.52
Discount to fair value	-28.6%
Smart-money phase	Early Load
Confidence score	51/100
RSI (14)	42.0
P/E	18.5
ROE	9.1%
Dividend yield	—%
52-week range	Rs 36.00 – Rs 85.82
Sector	Pharmaceuticals
Shariah-compliant	Yes ☪

✅ Get IBLHL signals free — create your ZEME account 📈 Live interactive chart & signals 💬 Ask ZEME about IBLHL

IBLHL (IBL Healthcare Limited) trades at Rs 41.37 on the Pakistan Stock Exchange, in the Early Load smart-money phase — starting to accumulate. ZEME's model puts fair value near Rs 29.52, making it about 28.6% overvalued. Smart money is starting to accumulate — the earliest stage of a potential move.

ZEME AI reads IBLHL through operator accumulation/distribution phases, fair value across three methods, RSI and volume, plus institutional flow (FIPI/LIPI & off-market) — the same smart-money engine behind our daily PSX signals. For the live chart, entry/stop/target and history, open the interactive analysis above.

Is IBLHL a buy right now?

Constructive — ZEME sees smart-money accumulation; check the entry vs the load zone. Smart money is starting to accumulate — the earliest stage of a potential move. As of 16 Oct 2026, IBLHL is in the Early Load phase with a ZEME confidence score of 51/100.

What is IBLHL's fair value?

ZEME estimates IBLHL's fair value at about Rs 29.52, versus a market price of Rs 41.37 — roughly 28.6% overvalued.

What smart-money phase is IBLHL in?

IBLHL is currently in the Early Load phase. Smart money is starting to accumulate — the earliest stage of a potential move.

More Pharmaceuticals stocks Fundamentals Dividend blue-chips ✓ Track record

Data updated 16 Oct 2026 from ZEME AI's PSX engine. Educational analytics, not investment advice — do your own research and use a stop loss. Trading carries risk.